Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 140

1.

Tuberculosis in sub-Saharan Africa: opportunities, challenges, and change in the era of antiretroviral treatment.

Corbett EL, Marston B, Churchyard GJ, De Cock KM.

Lancet. 2006 Mar 18;367(9514):926-37. Review.

PMID:
16546541
2.

Scaling up antiretroviral therapy in Africa: learning from tuberculosis control programmes--the case of Malawi.

Libamba E, Makombe S, Harries AD, Chimzizi R, Salaniponi FM, Schouten EJ, Mpazanje R.

Int J Tuberc Lung Dis. 2005 Oct;9(10):1062-71.

PMID:
16229216
3.

Tuberculosis and HIV interaction in sub-Saharan Africa: impact on patients and programmes; implications for policies.

Maher D, Harries A, Getahun H.

Trop Med Int Health. 2005 Aug;10(8):734-42. Review.

4.

Managing tuberculosis and HIV in sub-Sahara Africa.

Lalloo UG, Pillay S.

Curr HIV/AIDS Rep. 2008 Aug;5(3):132-9. Review.

PMID:
18627662
5.

Contemporary treatment of tuberculosis in HIV prevalent countries in sub-Saharan Africa.

Nuwaha F.

East Afr Med J. 1998 Jun;75(6):358-63. Review.

PMID:
9803621
6.
7.

Highly active antiretroviral therapy and tuberculosis control in Africa: synergies and potential.

Harries AD, Hargreaves NJ, Chimzizi R, Salaniponi FM.

Bull World Health Organ. 2002;80(6):464-9.

8.

Antiretroviral therapy in sub-Saharan Africa: adherence lessons from tuberculosis and leprosy.

Reid SE, Reid CA, Vermund SH.

Int J STD AIDS. 2004 Nov;15(11):713-6. Review.

PMID:
15537453
9.

[HIV and tuberculosis: new perspectives for diagnosis and treatment].

Zellweger JP.

Rev Med Suisse. 2006 Nov 15;2(87):2616-9. Review. French.

PMID:
17343152
10.

Tuberculosis case fatality rates in high HIV prevalence populations in sub-Saharan Africa.

Mukadi YD, Maher D, Harries A.

AIDS. 2001 Jan 26;15(2):143-52. Review.

PMID:
11216921
11.

A systematic review of missed opportunities for improving tuberculosis and HIV/AIDS control in Sub-saharan Africa: what is still missed by health experts?

Keugoung B, Fouelifack FY, Fotsing R, Macq J, Meli J, Criel B.

Pan Afr Med J. 2014 Aug 21;18:320. doi: 10.11604/pamj.2014.18.320.4066. Review.

12.

Setting the stage: current state of affairs and major challenges.

Reynolds SJ, Quinn TC.

Clin Infect Dis. 2010 May 15;50 Suppl 3:S71-6. doi: 10.1086/651476. Review.

13.

Survival of a large cohort of HIV-infected tuberculosis patients in the era of highly active antiretroviral treatment.

Català L, Orcau A, García de Olalla P, Millet JP, Rodríguez-Mondragón A, Caylà JA; TB-HIV Working Group..

Int J Tuberc Lung Dis. 2011 Feb;15(2):263-9, i.

PMID:
21219692
14.

Chemoprophylaxis for tuberculosis in HIV-infected individuals in sub-Saharan Africa.

Nuwaha F.

East Afr Med J. 1998 Sep;75(9):520-7. Review.

PMID:
10493054
15.

The HIV-associated tuberculosis epidemic--when will we act?

Harries AD, Zachariah R, Corbett EL, Lawn SD, Santos-Filho ET, Chimzizi R, Harrington M, Maher D, Williams BG, De Cock KM.

Lancet. 2010 May 29;375(9729):1906-19. doi: 10.1016/S0140-6736(10)60409-6. Review.

PMID:
20488516
16.

Early treatment outcomes and HIV status of patients with extensively drug-resistant tuberculosis in South Africa: a retrospective cohort study.

Dheda K, Shean K, Zumla A, Badri M, Streicher EM, Page-Shipp L, Willcox P, John MA, Reubenson G, Govindasamy D, Wong M, Padanilam X, Dziwiecki A, van Helden PD, Siwendu S, Jarand J, Menezes CN, Burns A, Victor T, Warren R, Grobusch MP, van der Walt M, Kvasnovsky C.

Lancet. 2010 May 22;375(9728):1798-807. doi: 10.1016/S0140-6736(10)60492-8.

17.

HIV and tuberculosis in prisons in sub-Saharan Africa.

Telisinghe L, Charalambous S, Topp SM, Herce ME, Hoffmann CJ, Barron P, Schouten EJ, Jahn A, Zachariah R, Harries AD, Beyrer C, Amon JJ.

Lancet. 2016 Sep 17;388(10050):1215-27. doi: 10.1016/S0140-6736(16)30578-5. Review.

PMID:
27427448
18.

[Severe opportunistic infections in HIV-positive adults in sub-Saharan Africa].

Anglaret X.

Med Trop (Mars). 2006 Aug;66(4):343-5. French.

PMID:
16999042
19.

Reducing deaths from tuberculosis in antiretroviral treatment programmes in sub-Saharan Africa.

Lawn SD, Harries AD, Meintjes G, Getahun H, Havlir DV, Wood R.

AIDS. 2012 Nov 13;26(17):2121-33. doi: 10.1097/QAD.0b013e3283565dd1. Review.

20.

Trials of anti-tuberculosis treatment in areas of high human immunodeficiency virus prevalence in sub-Saharan Africa.

Harries AD, Hargreaves NJ, Kumwenda J, Kwanjana JH, Salaniponi FM.

Int J Tuberc Lung Dis. 2000 Nov;4(11):998-1001.

PMID:
11092710
Items per page

Supplemental Content

Support Center